Pharmaceutical Practice for Treatment of Methicillin Resistant Staphylococcus Aureus Osteomyelitis in Children with Augmented Renal Clearance by Clinical Pharmacists
He Cuiyao, Wu Qing, Lyu Fengjun, et al. Pharmaceutical Practice for Treatment of Methicillin Resistant Staphylococcus Aureus Osteomyelitis in Children with Augmented Renal Clearance by Clinical Pharmacists[J]. 2021,27(1):45-49.
He Cuiyao, Wu Qing, Lyu Fengjun, et al. Pharmaceutical Practice for Treatment of Methicillin Resistant Staphylococcus Aureus Osteomyelitis in Children with Augmented Renal Clearance by Clinical Pharmacists[J]. 2021,27(1):45-49. DOI: 10.13407/j.cnki.jpp.1672-108X.2021.01.014.
Objective: To probe into the role of clinical pharmacists in the individualized treatment of anti-infection for methicillin resistant staphylococcus aureus (MRSA) osteomyelitis in children. Methods: Clinical pharmacists participated into the consultation of a case of failure in vancomycin treatment of acute osteomyelitis. Based on the patient’s clinical conditions and relevant examination results
combined with domestic and foreign literature
the causes for the failure of vancomycin treatment were analyzed from the perspective of PK/PD
and the alternative treatment regimen after vancomycin treatment failure was proposed. Results: The treatment regimen suggested by the clinical pharmacists was adopted by the clinicians
the bone and joint infection in the patient was effectively controlled. Conclusion: Clinical pharmacists give full play to the pharmaceutical expertise to guide use of antibiotics in special populations
which can effectively improve the efficacy of antibiotics in clinical treatment.